Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Critical Reviews in Oncology/Hematology|May 22, 2019
Whole-body hyperthermia in combination with systemic therapy in advanced solid malignanciesG Lassche, J Crezee, C M L Van HerpenOral Oncology|January 7, 2022
Case series of docetaxel, trastuzumab, and pertuzumab (DTP) as first line anti-HER2 therapy and ado-trastuzumab emtansine (T-DM1) as second line for recurrent or metastatic HER2-positive salivary duct carcinomaM J M Uijen, G Lassche, A C H van Engen-van Grunsven, et al.Nederlands Tijdschrift Voor Geneeskunde|August 12, 2020
[Salivary gland carcinoma]G Lassche, A C H van Engen-van Grunsven, J Honings, et al.Cancer Treatment Reviews|July 28, 2020
Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic reviewM J M Uijen, G Lassche, A C H van Engen-van Grunsven, et al.BMC Cancer|September 20, 2024
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocolJetty A M Weijers, Gerald W Verhaegh, G Lassche, et al.Pageof 1